These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3838971)

  • 21. Pharmacokinetics and urinary excretion of clavulanic acid after oral administration of amoxicillin and potassium clavulanate.
    Ferslew KE; Daigneault EA; Aten EM; Roseman JM
    J Clin Pharmacol; 1984 Oct; 24(10):452-6. PubMed ID: 6511988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibiotic persistence and tolerance in the lactating sheep following a course of intramammary therapy.
    Buswell JF; Barber DM
    Br Vet J; 1989; 145(6):552-7. PubMed ID: 2590825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A clinical and bacteriological evaluation of Augmentin: a new broad spectrum antibiotic in general practice.
    Hansrod D; Howalder R; Rozar GJ
    East Afr Med J; 1983 Nov; 60(11):778-82. PubMed ID: 6368188
    [No Abstract]   [Full Text] [Related]  

  • 24. [Augmentin in the clinical picture of infectious diseases].
    Gracheva NM; Petrova MS; Avakov AA; Bobovnikova VT
    Antibiot Khimioter; 1992 Sep; 37(9):25-7. PubMed ID: 1444664
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentin therapy in the treatment of urinary tract infections in general practice.
    Abbas AM; Goel PK; Venkit N; Gowers E
    Br J Clin Pract; 1984 Feb; 38(2):49-51. PubMed ID: 6704296
    [No Abstract]   [Full Text] [Related]  

  • 26. Bioavailability and pharmacokinetics of clavulanic acid in healthy subjects.
    Davies BE; Coates PE; Clarke JG; Thawley AR; Sutton JA
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):70-3. PubMed ID: 3872847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of twice-daily amoxycillin/clavulanate ('Augmentin-Duo' 400/57) in mild to moderate lower respiratory tract infection in children.
    Cook RC; Zachariah J; Cree F; Harrison HE
    Br J Clin Pract; 1996; 50(3):125-8. PubMed ID: 8733329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Augmentin].
    Mousset C; Schmidt M
    Soins Gynecol Obstet Pueric Pediatr; 1986 Oct; (65):I-II. PubMed ID: 3646763
    [No Abstract]   [Full Text] [Related]  

  • 29. An initial assessment of augmentin for the treatment of paediatric infections in general practice.
    Jeffries MG; Rose AJ; Williams HN
    Br J Clin Pract; 1983 Feb; 37(2):61-6. PubMed ID: 6860540
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of augmentin with co-trimoxazole for treatment of uncomplicated urinary tract infections.
    Bailey RR; Bishop V; Peddie B; Chambers PF; Davies PR; Crofts HG
    N Z Med J; 1983 Nov; 96(744):970-2. PubMed ID: 6605501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of amoxicillin and clavulanic acid administered alone and in combination.
    Adam D; de Visser I; Koeppe P
    Antimicrob Agents Chemother; 1982 Sep; 22(3):353-7. PubMed ID: 7137979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the antistaphylococcal activity of serum from healthy subjects taking flucloxacillin or augmentin.
    Thomas MG; Gillies M; Roberts S; Lang SD
    N Z Med J; 1985 Jun; 98(780):452-3. PubMed ID: 3858743
    [No Abstract]   [Full Text] [Related]  

  • 33. Influence of the antacid Maalox and the H2-antagonist cimetidine on the pharmacokinetics of cerivastatin.
    Mück W; Ritter W; Dietrich H; Frey R; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):261-4. PubMed ID: 9208343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A combination of amoxycillin with clavulanic acid (Augmentin) in various types of urinary tract infections caused by microbes producing beta-lactamase].
    Prát V; Horcicková M; Hatala M; Liska M; Matousovic K
    Cas Lek Cesk; 1985 Jun; 124(23):711-4. PubMed ID: 3874692
    [No Abstract]   [Full Text] [Related]  

  • 35. Augmentin (Amoxycillin and clavulanic acid) in the treatment of urinary tract infections and skin and soft tissue infections.
    Tan TH; Tay L; Yeo M; Feng PH
    Singapore Med J; 1983 Oct; 24(5):299-302. PubMed ID: 6669995
    [No Abstract]   [Full Text] [Related]  

  • 36. [Preliminary evaluation of the sensitivity of selected bacteria to amoxicillin and augmentin in comparison with other antibiotics used to date].
    Ruczkowska J; Dolna I
    Przegl Lek; 1984; 41(4):321-4. PubMed ID: 6565294
    [No Abstract]   [Full Text] [Related]  

  • 37. Lack of influence of aluminum hydroxide on the bioavailability and beta-adrenoceptor blocking activity of propranolol.
    Hong CY; Hu SC; Lin SJ; Chiang BN
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):244-6. PubMed ID: 4008113
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of ranitidine, pirenzepine, and aluminum magnesium hydroxide on the bioavailability of various antibiotics, including amoxicillin, cephalexin, doxycycline, and amoxicillin-clavulanic acid.
    Deppermann KM; Lode H; Höffken G; Tschink G; Kalz C; Koeppe P
    Antimicrob Agents Chemother; 1989 Nov; 33(11):1901-7. PubMed ID: 2610502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.
    Schaad UB; Casey PA; Cooper DL
    Antimicrob Agents Chemother; 1983 Feb; 23(2):252-5. PubMed ID: 6838187
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing role of co-trimoxazole in the treatment of recurrent urinary infections: a comparison with augmentin.
    Brumfitt W; Hamilton-Miller JM
    Br J Clin Pract; 1985 Sep; 39(9):346-51. PubMed ID: 3904797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.